Pharma

Sanofi halts amlitelimab development for atopic dermatitis following pipeline review

Despite positive long-term efficacy and safety data, the biopharma has concluded its OX40L antibody would not offer a meaningful improvement over current standards of care and will no longer pursue regulatory approval for the indication.

Kolon TissueGene's Knee Osteoarthritis Therapy Fails Phase 3 Trial

Second late-stage study due in October will decide the fate of the cell-based gene therapy programme

FairJourney Bio Expands End-to-End Antibody Discovery Through New AbTherx Partnership

FairJourney Bio has announced a strategic partnership with AbTherx to bring transgenic mouse-based antibody discovery capabilities in-house, creating a fully integrated antibody discovery workflow designed to accelerate therapeutic development.

How Automation is Accelerating Drug Discovery Timelines

The discovery of new drugs is vital for improving the lives but can be expensive and time consuming to research, here is how automation is helping to speed up this process.

Innovent Biologics and Pfizer Forge $10.5 Billion Oncology Partnership

Strategic collaboration combines Innovent’s early-stage oncology innovation platform with Pfizer’s global development and commercial capabilities across 12 cancer programs.

AI in Science Writing and the Imitation of Understanding

As AI becomes more fluent in science writing, the line between sounding right and being right starts to blur.